Pregled bibliografske jedinice broj: 1155106
AICAr, a widely used AMPK activator with important AMPK-independent effects: a systematic review
AICAr, a widely used AMPK activator with important AMPK-independent effects: a systematic review // Cells, 10 (2021), 5; 1095, 17 doi:10.3390/cells10051095 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1155106 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
AICAr, a widely used AMPK activator with important
AMPK-independent effects: a systematic review
Autori
Višnjić, Dora ; Lalić, Hrvoje ; Dembitz, Vilma ; Tomić, Barbara ; Smoljo, Tomislav
Izvornik
Cells (2073-4409) 10
(2021), 5;
1095, 17
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
AICAr ; AMPK ; metabolism ; acadesine ; exercise ; cell cycle ; purine ; pyrimidine ; cancer ; leukemia
Sažetak
5-Aminoimidazole-4-carboxamide ribonucleoside (AICAr) has been one of the most commonly used pharmacological modulators of AMPK activity. The majority of early studies on the role of AMPK, both in the physiological regulation of metabolism and in cancer pathogenesis, were based solely on the use of AICAr as an AMPK-activator. Even with more complex models of AMPK downregulation and knockout being introduced, AICAr remained a regular starting point for many studies focusing on AMPK biology. However, there is an increasing number of studies showing that numerous AICAr effects, previously attributed to AMPK activation, are in fact AMPK-independent. This review aims to give an overview of the present knowledge on AMPK- dependent and AMPK-independent effects of AICAr on metabolism, hypoxia, exercise, nucleotide synthesis, and cancer, calling for caution in the interpretation of AICAr-based studies in the context of understanding AMPK signaling pathway.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Projekti:
--IP-2016-06-4581 - Signalni mehanizmi i metaboličke promjene u diferencijaciji stanica akutne mijeloične leukemije (SignalmetabAML) (Višnjić, Dora) ( CroRIS)
--KK.01.1.1.01.0007 - Znanstveni centar izvrnosti - Eksperimentalna i klinička istraživanja hipoksijsko-ishemijskog oštećenja mozga u perinatalnoj i odrasloj dobi (ZCI - NEURO) (Judaš, Miloš) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Barbara Tomić
(autor)
Hrvoje Lalić
(autor)
Dora Višnjić
(autor)
Tomislav Smoljo
(autor)
Vilma Dembitz
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE